- Home
- NPCE vs NAUT Comparison
NPCE vs NAUT Comparison
Compare NPCE & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- NAUT
- Stock Information
- Founded
- NPCE 1997
- NAUT 2016
- Country
- NPCE United States
- NAUT United States
- Employees
- NPCE N/A
- NAUT N/A
- Industry
- NPCE Medical Specialities
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- NPCE Health Care
- NAUT Industrials
- Exchange
- NPCE Nasdaq
- NAUT Nasdaq
- Market Cap
- NPCE 336.7M
- NAUT 284.7M
- IPO Year
- NPCE 2021
- NAUT N/A
- Fundamental
- Price
- NPCE $10.64
- NAUT $1.81
- Analyst Decision
- NPCE Buy
- NAUT Hold
- Analyst Count
- NPCE 7
- NAUT 3
- Target Price
- NPCE $15.29
- NAUT $3.58
- AVG Volume (30 Days)
- NPCE 67.6K
- NAUT 132.0K
- Earning Date
- NPCE 11-12-2024
- NAUT 10-29-2024
- Dividend Yield
- NPCE N/A
- NAUT N/A
- EPS Growth
- NPCE N/A
- NAUT N/A
- EPS
- NPCE N/A
- NAUT N/A
- Revenue
- NPCE $76,452,000.00
- NAUT N/A
- Revenue This Year
- NPCE $23.46
- NAUT N/A
- Revenue Next Year
- NPCE $15.49
- NAUT N/A
- P/E Ratio
- NPCE N/A
- NAUT N/A
- Revenue Growth
- NPCE 27.00
- NAUT N/A
- 52 Week Low
- NPCE $5.45
- NAUT $1.80
- 52 Week High
- NPCE $18.15
- NAUT $3.46
- Technical
- Relative Strength Index (RSI)
- NPCE 54.53
- NAUT 32.10
- Support Level
- NPCE $10.00
- NAUT $1.88
- Resistance Level
- NPCE $12.41
- NAUT $2.21
- Average True Range (ATR)
- NPCE 1.04
- NAUT 0.16
- MACD
- NPCE -0.14
- NAUT -0.02
- Stochastic Oscillator
- NPCE 28.67
- NAUT 2.33
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.